China 2024 was another groundbreaking year for Chinese medicine approvals. Writing in the March 2025 edition of DIA’s Global Forum magazine, Juan Valencia S. and Angel Shao of PharmCube explain how and why. Driven by drugmakers’ growing interest in accessing the world’s second-largest pharmaceutical market, China has recently seen a…
See our Cookie Privacy Policy Here
